This study is evaluating a treatment called Umbilical Allograft for people with musculoskeletal conditions like osteoarthritis, tendinitis, sports injuries, degenerative disc disease, and degenerative arthritis. The Umbilical Allograft is a product regulated by the FDA and comes from an FDA-registered lab. Researchers want to see if this treatment can help reduce pain and improve function. To join, you must be at least 18 years old and able to attend follow-up visits or complete forms. You cannot participate if you have an active infection, are pregnant or lactating, or have a clotting disorder. The study will measure improvements in your musculoskeletal function over one year.

Study design

This is an interventional study with a planned enrollment of 200 participants. It is a prospective study, meaning outcomes are tracked forward in time.

What's involved

You would need to attend follow-up visits or complete forms at 4 weeks, 3 months, 6 months, 9 months, and one year after the procedure.

Compensation

Not stated in the trial record.

Follow-up

Participants will be followed for one year after the intervention to assess changes in musculoskeletal function.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.